Literature DB >> 28178070

Prolonged changes in amyloid-β metabolism after a severe traumatic brain injury.

Sergio Bagnato1, Maria Andriolo, Cristina Boccagni, Giuseppe Galardi.   

Abstract

Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease. Recent studies suggest that amyloid-beta (Aβ) deposit can be detected several years after TBI. However, it is unknown whether post-TBI Aβ deposits arise from short-term changes in Aβ metabolism or reflect a long-term sequela. To answer this question, we evaluated the cerebrospinal levels of Aβ several months after a severe TBI. The participants of this study were eight consecutive patients who developed a disorder of consciousness after a TBI, including seven in a minimally conscious state and one with unresponsive wakefulness syndrome (mean age: 35.4±14.2 years, mean time since brain injury 297.9±189.8 days). Cerebrospinal Aβ1-42 peptide was measured using a commercially available Aβ enzyme-linked immunoassay kit. Reduced Aβ1-42 levels were observed in seven of eight (87.5%) patients with severe post-TBI disorders of consciousness, with the magnitude of reduction among these seven patients ranging from 27 to 75.1% of the lower normal limit. These results point to prolonged changes in Aβ metabolism after a TBI and they suggest a potential mechanism of long-term neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28178070     DOI: 10.1097/WNR.0000000000000748

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  2 in total

Review 1.  Military-related risk factors for dementia.

Authors:  Heather M Snyder; Roxana O Carare; Steven T DeKosky; Mony J de Leon; Derek Dykxhoorn; Li Gan; Raquel Gardner; Sidney R Hinds; Michael Jaffee; Bruce T Lamb; Susan Landau; Geoff Manley; Ann McKee; Daniel Perl; Julie A Schneider; Michael Weiner; Cheryl Wellington; Kristine Yaffe; Lisa Bain; Anthony M Pacifico; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2018-11-08       Impact factor: 21.566

Review 2.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.